Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Rationale for perioperative anticancer treatment.

Schabel FM Jr.

Recent Results Cancer Res. 1985;98:1-10. No abstract available.

PMID:
4035066
2.

Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology.

Schabel FM Jr, Griswold DP Jr, Corbett TH, Laster WR Jr.

Cancer. 1984 Sep 15;54(6 Suppl):1160-7. No abstract available.

PMID:
6467147
3.

Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.

Corbett TH, Roberts BJ, Leopold WR, Peckham JC, Wilkoff LJ, Griswold DP Jr, Schabel FM Jr.

Cancer Res. 1984 Feb;44(2):717-26.

4.
5.

Therapeutic activity of mitoxantrone and ametantrone against murine tumors.

Schabel FM Jr, Corbett TH, Griswold DP Jr, Laster WR Jr, Trader MW.

Cancer Treat Rev. 1983 Dec;10 Suppl B:13-21. Review. No abstract available.

PMID:
6362874
6.

Establishment of cross-resistance profiles for new agents.

Schabel FM Jr, Skipper HE, Trader MW, Laster WR Jr, Griswold DP Jr, Corbett TH.

Cancer Treat Rep. 1983 Oct;67(10):905-22. Review.

PMID:
6354439
7.

Concepts for the treatment of tumor metastasis.

Griswold DP Jr, Schabel FM Jr, Dykes DJ, Trader MW, Laster WR Jr.

Symp Fundam Cancer Res. 1983;36:389-96. Review. No abstract available.

PMID:
6382515
8.

Increasing therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology.

Schabel FM Jr, Griswold DP Jr, Corbett TH, Laster WR Jr.

Pharmacol Ther. 1983;20(2):283-305. Review. No abstract available.

PMID:
6351113
9.

Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents.

Corbett TH, Roberts BJ, Trader MW, Laster WR Jr, Griswold DP Jr, Schabel FM Jr.

Cancer Treat Rep. 1982 May;66(5):1187-200.

PMID:
7083221
10.

Toxicity and anticancer activity of a new triazine antifolate (NSC 127755).

Corbett TH, Leopold WR, Dykes DJ, Roberts BJ, Griswold DP Jr, Schabel FM Jr.

Cancer Res. 1982 May;42(5):1707-15.

11.

Drug control of Ara-C-resistant tumor cells.

Schabel FM Jr, Skipper HE, Trader MW, Brockman RW, Laster WR Jr, Corbett TH, Griswold DP Jr.

Med Pediatr Oncol. 1982;10 Suppl 1:125-48. No abstract available.

PMID:
7162459
12.

Synergistic antileukemic activity of combinations of two nitrosoureas.

Wheeler GP, Schabel FM Jr, Trader MW.

Cancer Treat Rep. 1981 Jul-Aug;65(7-8):591-9.

PMID:
6454482
13.

Clonogenicity and growth of experimental tumors in relation to developing resistance and therapeutic failure.

Griswold DP, Corbett TH, Schabel FM Jr.

Cancer Treat Rep. 1981;65 Suppl 2:51-4. No abstract available.

PMID:
7346146
14.

Clinical concepts derived from animal chemotherapy studies.

Goldin A, Schabel FM.

Cancer Treat Rep. 1981;65 Suppl 3:11-9. Review.

PMID:
7049366
15.

Absence of delayed lethality in mice treated with aclacinomycin A.

Corbett TH, Griswold DP Jr, Roberts BJ, Schabel FM Jr.

Cancer Chemother Pharmacol. 1981;6(2):161-8.

PMID:
6946879
16.
18.

Cell kinetics and the chemotherapy of murine solid tumors.

Schabel FM Jr, Corbett TH, Schabel FM Jr.

Antibiot Chemother (1971). 1980;28:28-34. No abstract available.

PMID:
7416729
19.

Antiviral agents as adjuncts in cancer chemotherapy.

Shannon WM, Schabel FM Jr.

Pharmacol Ther. 1980;11(2):263-390. Review. No abstract available.

PMID:
7001501
20.

Concepts for controlling drug-resistant tumor cells.

Schabel FM Jr, Skipper HE, Trader MW, Laster WR Jr, Corbett TH, Griswold DP Jr.

Eur J Cancer. 1980;Suppl 1:199-211. No abstract available.

PMID:
6947891
21.

cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.

Schabel FM Jr, Trader MW, Laster WR Jr, Corbett TH, Griswold DP Jr.

Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1459-73.

PMID:
291480
22.

Evaluation of whole-body hyperthermia as an adjunct to chemotherapy in murine tumors.

Rose WC, Veras GH, Laster WR Jr, Schabel FM Jr.

Cancer Treat Rep. 1979 Aug;63(8):1311-25. No abstract available.

PMID:
476708
23.

Design and evaluation of combination chemotherapy trials in experimental animal tumor systems.

Corbett TH, Griswold DP Jr, Wolpert MK, Venditti JM, Schabel FM Jr.

Cancer Treat Rep. 1979 May;63(5):799-801. No abstract available.

PMID:
455319
24.

Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.

Rose WC, Trader MW, Dykes DJ, Laster WR Jr, Schabel FM Jr.

Cancer Treat Rep. 1978 Dec;62(12):2085-93.

PMID:
751716
25.

Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy.

Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr.

Cancer Treat Rep. 1978 Oct;62(10):1471-88.

PMID:
709550
26.

Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.

Rose WC, Trader MW, Laster WR Jr, Schabel FM Jr.

Cancer Treat Rep. 1978 Sep;62(9):1337-49. No abstract available.

PMID:
688277
27.

Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells.

Skipper HE, Schabel FM Jr, Lloyd HH.

Semin Hematol. 1978 Jul;15(3):207-19. No abstract available.

PMID:
675261
28.

Response of five established solid transplantable mouse tumors and one mouse leukemia to hyperbaric hydrogen.

Roberts BJ, Fife WP, Corbett TH, Schabel FM Jr.

Cancer Treat Rep. 1978 Jul;62(7):1077-9. No abstract available.

PMID:
99233
29.

Comparative antitumor activity of actinomycin analogs in mice bearing Ridgway osteogenic sarcoma or P388 leukemia.

Rose WC, Trader MW, Laster WR Jr, Schabel FM Jr.

Cancer Treat Rep. 1978 May;62(5):779-89.

PMID:
77730
30.

Application of cancer chemotherapy: Introduction.

Schabel FM Jr.

Antibiot Chemother (1971). 1978;24:1-3. No abstract available.

PMID:
655671
31.

Fundamentals in cancer chemotherapy: introduction.

Schabel FM Jr.

Antibiot Chemother (1971). 1978;23:1-3. No abstract available.

PMID:
646326
32.

Patterns of resistance and therapeutic synergism among alkylating agents.

Schabel FM Jr, Trader MW, Laster WR Jr, Wheeler GP, Witt MH.

Antibiot Chemother (1971). 1978;23:200-15. Review.

PMID:
348078
33.

Some variables in experimental tumor systems which complicate interpretation of data from in vivo kinetic and pharmacologic studies with anticancer drugs.

Schabel FM Jr, Simpson-Herren L.

Antibiot Chemother (1971). 1978;23:113-27. Review. No abstract available.

PMID:
348072
34.

Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine.

Brockman RW, Schabel FM Jr, Montgomery JA.

Biochem Pharmacol. 1977 Nov 15;26(22):2193-6. No abstract available.

PMID:
563233
35.

Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas.

Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr.

Cancer. 1977 Nov;40(5 Suppl):2660-80. No abstract available.

PMID:
922705
36.

Surgical adjuvant chemotherapy of metastatic murine tumors.

Schabel FM Jr.

Cancer. 1977 Jul;40(1 Suppl):558-68. No abstract available.

PMID:
884651
37.

Rationale for adjuvant chemotherapy.

Schabel FM Jr.

Cancer. 1977 Jun;39(6 Suppl):2875-82. Review. No abstract available.

PMID:
141322
39.

Growth support of small B16 melanoma implants with nitrosourea-sterilized fractions of the same tumor.

Dykes DJ, Griswold DP Jr, Schabel FM Jr.

Cancer Res. 1976 Jun;36(6):2031-4.

40.

Nitrosoureas: a review of experimental antitumor activity.

Schabel FM Jr.

Cancer Treat Rep. 1976 Jun;60(6):665-98. Review.

PMID:
782694
41.

Concepts for treatment of micrometastases developed in murine systems.

Schabel FM Jr.

AJR Am J Roentgenol. 1976 Mar;126(3):500-11. Review.

PMID:
178196
42.
43.
44.

The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.

Brockman RW, Shaddix SC, Williams M, Nelson JA, Rose LM, Schabel FM Jr.

Ann N Y Acad Sci. 1975 Aug 8;255:501-21.

PMID:
171997
45.

Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.

Corbett TH, Griswold DP, Mayo JG, Laster WR, Schabel FM Jr.

Cancer Res. 1975 Jun;35(6):1568-73.

46.

Antiviral chemotherapy as an indicated adjunct to cancer chemotherapy.

Schabel FM Jr.

Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):261-5. No abstract available.

PMID:
1149005
47.

Concepts for systemic treatment of micrometastases.

Schabel FM Jr.

Cancer. 1975 Jan;35(1):15-24.

PMID:
1109768
48.

Combination chemotherapy for spontaneous AKR lymphoma.

Schabel FM Jr, Skipper HE, Trader MW, Laster WR Jr, Cheeks JB.

Cancer Chemother Rep 2. 1974 Mar;4(1):53-72. No abstract available.

PMID:
4499910
49.

Antiviral activity of 9-beta-D-arabinofuranosyladenine (ara-A) against Gross murine leukemia virus in vitro.

Shannon WM, Westbrook L, Schabel FM Jr.

Proc Soc Exp Biol Med. 1974 Feb;145(2):542-5. No abstract available.

PMID:
4855983
50.

Inhibition of gross leukemia virus-induced plaque formation in XC cells by 3-deazauridine.

Shannon WM, Brockman RW, Westbrook L, Shaddix S, Schabel FM Jr.

J Natl Cancer Inst. 1974 Jan;52(1):199-205. No abstract available.

PMID:
4855758

Supplemental Content

Loading ...
Support Center